Ruining Bio
Ruining Bio provides clinical medical solutions such as tumor radiotherapy protection and wound repair.
Funding reportedLast round: Series B
What company datasets say Ruining Bio raised
Funding, as reported
Reported in all200Min the source's currency
Rounds2
Last roundSeries B
Last round dateJan 2024
Investors listed6
Medical in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Ruining Bio in front of investors. Or tell us what we have wrong.